Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;5(1):57-64.
doi: 10.15420/aer.2016.2.3.

Pacing and Defibrillators in Complex Congenital Heart Disease

Henry Chubb  1 , Mark O'Neill  2 , Eric Rosenthal  3
Affiliations

Pacing and Defibrillators in Complex Congenital Heart Disease

Henry Chubb et al. Arrhythm Electrophysiol Rev. 2016 May.

Abstract

Device therapy in the complex congenital heart disease (CHD) population is a challenging field. There is a myriad of devices available, but none designed specifically for the CHD patient group, and a scarcity of prospective studies to guide best practice. Baseline cardiac anatomy, prior surgical and interventional procedures, existing tachyarrhythmias and the requirement for future intervention all play a substantial role in decision making. For both pacing systems and implantable cardioverter defibrillators, numerous factors impact on the merits of system location (endovascular versus non-endovascular), lead positioning, device selection and device programming. For those with Fontan circulation and following the atrial switch procedure there are also very specific considerations regarding access and potential complications. This review discusses the published guidelines, device indications and the best available evidence for guidance of device implantation in the complex CHD population.

Keywords: Congenital heart disease; arrhythmia; cardiac resynchronisation therapy; implantable cardioverter defibrillator; pacing; sudden cardiac death.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Pacing Solutions in Patients with Hemi-Fontan Circulation, or Similar
Figure 2:
Figure 2:. Pacing in Patients with a Fontan Circulation
Figure 3:
Figure 3:. Pacing Following Atrial Switch Procedure
See this image and copyright information in PMC

References

    1. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2008;118:e714––e833. DOI: 10.1161/CIRCULATIONAHA.108.190690; PMID: 18997169. - PubMed
    1. Khairy P, Van Hare GF, Balaji S et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Heart Rhythm. 2014;11:e102––e65. DOI: 10.1016/j.hrthm.2014.05.009; PMID: 24814377. - PubMed
    1. Bhatt AB, Foster E, Kuehl K, et al. Congenital Heart Disease in the Older Adult A Scientific Statement From the American Heart Association. Circulation. 2015;131 1884-931 DOI: 10.1161/CIR.0000000000000204; PMID: 25896865. - PubMed
    1. Czosek RJ, Anderson J, Khoury PR, et al. Utility of ambulatory monitoring in patients with congenital heart disease. Am J Cardiol. 2013;111:723–30. DOI: 10.1016/j.amjcard.2012.11.021; PMID: 23246250. - PubMed
    1. Khairy P, Aboulhosn J, Gurvitz MZ et al. for the Alliance for Adult Research in Congenital Cardiology (AARCC). Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: A Multi-Institutional Study. Circulation. 2010;122:868–75. DOI: 10.1161/CIRCULATIONAHA.109.928481; PMID: 20713900. - PubMed

LinkOut - more resources